These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34499622)

  • 21. Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.
    Arita-Okubo S; Kim-Kaneyama JR; Lei XF; Fu WG; Ohnishi K; Takeya M; Miyauchi A; Honda H; Itabe H; Miyazaki T; Miyazaki A
    Cardiovasc Res; 2015 Mar; 105(3):361-71. PubMed ID: 25587044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration.
    Sun C; Wu MH; Yuan SY
    Circulation; 2011 Jul; 124(1):48-57. PubMed ID: 21670231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of Endothelial CD40 Induces a Stable Plaque Phenotype and Limits Inflammatory Cell Recruitment to Atherosclerotic Lesions in Mice.
    Gissler MC; Scherrer P; Anto-Michel N; Pennig J; Hoppe N; Füner L; Härdtner C; Stachon P; Li X; Mitre LS; Marchini T; Madl J; Wadle C; Hilgendorf I; von Zur Mühlen C; Bode C; Weber C; Lutgens E; Wolf D; Gerdes N; Zirlik A; Willecke F
    Thromb Haemost; 2021 Nov; 121(11):1530-1540. PubMed ID: 33618394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
    Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
    Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes.
    Fujisawa T; Wang K; Niu XL; Egginton S; Ahmad S; Hewett P; Kontos CD; Ahmed A
    Cardiovasc Res; 2017 Jan; 113(1):81-89. PubMed ID: 28069704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gas6 Promotes Inflammatory (CCR2
    Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
    Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
    J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation.
    Sun H; Jiang J; Gong L; Li X; Yang Y; Luo Y; Guo Z; Lu R; Li H; Li J; Zhao J; Yang N; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109352. PubMed ID: 31586905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.
    Verstak B; Stack J; Ve T; Mangan M; Hjerrild K; Jeon J; Stahl R; Latz E; Gay N; Kobe B; Bowie AG; Mansell A
    J Leukoc Biol; 2014 Sep; 96(3):427-36. PubMed ID: 24812060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
    Chen H; Yang J; Zhang Q; Chen LH; Wang Q
    Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.
    Majmudar MD; Keliher EJ; Heidt T; Leuschner F; Truelove J; Sena BF; Gorbatov R; Iwamoto Y; Dutta P; Wojtkiewicz G; Courties G; Sebas M; Borodovsky A; Fitzgerald K; Nolte MW; Dickneite G; Chen JW; Anderson DG; Swirski FK; Weissleder R; Nahrendorf M
    Circulation; 2013 May; 127(20):2038-46. PubMed ID: 23616627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.
    Wang J; Ma A; Zhao M; Zhu H
    Atherosclerosis; 2017 Mar; 258():97-107. PubMed ID: 28235712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α
    Zhang Y; Shi X; Han J; Peng W; Fang Z; Zhou Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
    Drug Des Devel Ther; 2021; 15():803-812. PubMed ID: 33654384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid
    Huo M; Huang Y; Qu D; Zhang H; Wong WT; Chawla A; Huang Y; Tian XY
    FASEB J; 2017 Mar; 31(3):1097-1106. PubMed ID: 27927724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.
    Rahman K; Vengrenyuk Y; Ramsey SA; Vila NR; Girgis NM; Liu J; Gusarova V; Gromada J; Weinstock A; Moore KJ; Loke P; Fisher EA
    J Clin Invest; 2017 Aug; 127(8):2904-2915. PubMed ID: 28650342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.
    Zhang M; Zhu H; Ding Y; Liu Z; Cai Z; Zou MH
    J Biol Chem; 2017 May; 292(19):7888-7903. PubMed ID: 28330873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments.
    Shibata K; Sato K; Shirai R; Seki T; Okano T; Yamashita T; Koide A; Mitsuboshi M; Mori Y; Hirano T; Watanabe T
    Heart Vessels; 2020 Jul; 35(7):1012-1024. PubMed ID: 31960147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
    Xu L; Dai Perrard X; Perrard JL; Yang D; Xiao X; Teng BB; Simon SI; Ballantyne CM; Wu H
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1787-97. PubMed ID: 26112011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.